DNA self-assembly nanoflower reverse P-glycoprotein mediated drug resistance in chronic myelogenous leukemia therapy
Open Access
- 21 August 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 11, 1265199
Abstract
Introduction: Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorder caused by the BCR-ABL chimeric tyrosine kinase. Vincristine (VCR) is widely used in leukemia therapy but is hindered by multidrug resistance (MDR).Methods: We prepared DNA nanoflower via self-assembly for the delivery of VCR and P-glycoprotein small interfering RNA (P-gp siRNA).Results and Discussion: The as-prepared nanoflower had a floriform shape with high loading efficiency of VCR (80%). Furthermore, the nanoflower could deliver VCR and P-gp siRNA into MDR CML cells and induce potent cytotoxicity both in vitro and in vivo, thus overcoming MDR of CML. Overall, this nanoflower is a promising tool for resistant CML therapy.Keywords
This publication has 41 references indexed in Scilit:
- Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in VivoACS Nano, 2013
- Engineering Polymeric Aptamers for Selective CytotoxicityJournal of the American Chemical Society, 2011
- Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibitionJournal of Controlled Release, 2010
- Aptamers as therapeuticsNature Reviews Drug Discovery, 2010
- Aptamers evolved from live cells as effective molecular probes for cancer studyProceedings of the National Academy of Sciences, 2006
- The Biology of Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Chronic myelogenous leukemia: A reviewThe American Journal of Medicine, 1996
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990
- Characteristics of accelerated disease in chronic myelogenous leukemiaCancer, 1988
- Structures of Leurocristine (Vincristine) and Vincaleukoblastine.1 X-Ray Analysis of Leurocristine MethiodideJournal of the American Chemical Society, 1965